Table 2.
Crosstab between study variables and clinical outcome.
| Study Variables | Clinical outcome | total | |
|---|---|---|---|
| cured/improvement, N (%) | stable/progression N (%) | ||
| Sex | |||
| Male | 6 (54.5%) | 5 (45.5%) | 11 |
| Female | 15 (71.4%) | 6 (28.6%) | 21 |
| Total | 21 (65.6%) | 11 (34.4%) | 32 |
| Age | |||
| <50 years | 3 (60%) | 2 (40%) | 5 |
| > 50 years | 18 (66.7%) | 9 (33.3%) | 27 |
| Underlying disease | |||
| Osteoporosis | 8 (72.7%) | 3 (27.3%) | 11 |
| Malignant | 13 (61.9%) | 8 (38.1%) | 21 |
| Stage | |||
| I | 4 (80%) | 1 (20%) | 5 |
| II | 12 (66.7%) | 6 (33.3) | 18 |
| III | 5 (55.6%) | 4 (44.4%) | 9 |
| BPs consumption | |||
| <12 months | 4 (80%) | 1 (20%) | 5 |
| 12 to 36 | 11 (61.1%) | 7 (38.9%) | 18 |
| >36 months | 6 (66.7%) | 3 (33.3%) | 9 |
| BPs intake | |||
| IV+(IV+PO) | 16 (61.5%) | 10 (38.7%) | 26 |
| PO | 5 (83.3%) | 1 (16.7%) | 6 |
| (IV+PO) +PO | 9 (81.8%) | 2 (18.2) | 11 |
| IV | 12 (57.1%) | 9 (42.9%) | 21 |
| TIMING OF TOOTH EXTRACTION | |||
| During BPs therapy | 16 (69.6%) | 7 (30.4%) | 23 |
| After cessation of BPs therapy | 5 (55.6%) | 4 (44.4%) | 9 |
| Chemotherapy | |||
| Yes | 11 (64.7%) | 6 (35.3%) | 7 |
| No | 2(50%) | 2(50%) | 4 |
| Bone metastasis | |||
| Yes | 9 (64.3%) | 5 (35.7%) | 14 |
| No | 4 (57.1%) | 3 (42.9%) | 7 |
| Localisation | |||
| mandible | 15 (65.2%) | 8 (34.8%) | 23 |
| maxilla | 6 (66.7%) | 3 (33.3%) | 9 |
| Etiology | |||
| dental extraction-trauma | 20 (66.6%) | 10 (33.4%) | 30 |
| No dental extraction | 1 (50 %)) | 1 (50%) | 2 |
| Surgical approach | |||
| Surgical | 10 (55.6%) | 8 (44.4%) | 18 |
| Conservative | 11 (78.6%) | 3 (21.4%) | 14 |
(i) Data presented as n (%) or mean ± standard deviation.